科学专案合作伙伴
与日本抗体研究学会合作制定的会议议程
Accelerating Tomorrow's Antibody Therapeutics Today
The Summit of Antibody Science and Your Path to Commercial Success
Antibodies • Proteins • Bispecifics • Multispecifics • ADCs
What’s Waiting for You in Sunny San Diego
135+
World-Class Speaker Presentations
900+
Antibody Scientists & Executives
75+
Leading Industry Exhibitors
125+
Scientific Posters Highlighting Breakthrough Research
Where Antibody Breakthroughs Begin
Get an inside look at this year’s agenda - packed with world-class speakers and forward-thinking research across antibody engineering and therapeutic development.
Novel Bispecific and Multi-specific Antibodies
-
Explore advanced multispecific formats to overcome therapeutic limitations
-
Case studies on bispecific ADCs and conditional activation platforms
-
Engineering strategies for glycan targeting, avidity, and stability
Antibody Therapeutics in Emerging Disease Areas: Non-Oncology
-
Novel antibodies for fibrosis, cardiovascular disease, and CNS delivery
-
Innovative biologics targeting innate and adaptive immune pathways
-
Translating discoveries into therapies for complex non-oncology indications
Innovative Engineering for Cell Engagers
-
AI-driven design and next-gen T-cell engager platforms
-
Strategies to improve potency, selectivity, and safety in immunotherapy
-
Novel conditional engagers and dual-binding antibodies in cancer therapy
Antibody and Protein Therapeutics in Inflammation, Autoimmunity and Allergy
-
Breakthroughs in cell depletion strategies for autoimmune diseases
-
Next-gen cytokine blockers and trispecific antibodies for inflammation
-
Novel approaches to allergy treatment, from IgE cleavage to immune modulation
Emerging In Vitro Approaches to Antibody Discovery
-
Cutting-edge display technologies and high-throughput screening platforms
-
Computational and AI-driven antibody engineering for speed and precision
-
Case studies on de novo antibody design and rapid evolution systems
Engineering Innovative Formats and Scaffolds
-
Nanobody and knottin engineering for novel therapeutic applications
-
Advances in GPCR-targeting formats and allosteric modulators
-
Overcoming immunogenicity challenges with new scaffold architectures
Advanced In Vivo Antibody Discovery
-
Leveraging animal models and immune organoids for breakthrough discovery
-
In vivo screening approaches for CNS delivery and biodistribution
-
Strategies to accelerate discovery of antibodies against infectious diseases
Antibody Drug Conjugates - Novel Payloads and Engineering
-
Dual-payload ADCs for enhanced efficacy and resistance management
-
Site-specific conjugation techniques for stability and safety
-
Novel non-cytotoxic payloads and improved therapeutic index strategies
Engineering Considerations for Candidate Selection and Developability
-
Early risk mitigation for immunogenicity and chemical liabilities
-
ML-driven workflows for predictive developability optimization
-
High-throughput strategies for complex biologics like ADCs and bispecifics
Innovate, Invest, Succeed: The Business Landscape of Antibody Therapeutics
-
Investor perspectives on value creation and biotech funding trends
-
Lessons from successful preclinical-to-clinic transitions
-
Strategic insights for commercialization and portfolio optimization
Enhanced Efficacy Through Fc Engineering
-
Fc modifications to optimize effector function and immune activation
-
Site-specific conjugation and glycoengineering breakthroughs
-
Translating Fc innovations into next-gen therapeutics
Novel Extracellular Protein Degraders & Beyond
-
Cutting-edge eTPD platforms for transmembrane and extracellular targets
-
Novel bispecific degrader technologies and conjugate strategies
-
Expanding the druggable proteome beyond traditional antibody modalities
Discover the Keynote Speakers Driving Antibody Innovation
The Science. The Networking. The Moments.
Last year set the stage - 2025 will raise the bar. Watch the 2024 highlights, then join us this December in San Diego for the world’s leading antibody engineering event.
Ways to Attend
Join the Antibody Event of the Year in San Diego!
Get ready for 4 days of breakthrough science, powerful networking, and cutting-edge innovation at Antibody Engineering & Therapeutics US. This is your chance to:
✓ Access exclusive insights from 135+ world-renowned speakers sharing never-before-seen data and real-world case studies.
✓ Connect with 75+ leading solution providers driving the next wave of antibody engineering and therapeutic development.
✓ Explore the entire antibody landscape - from discovery and design to clinical development and commercialization.
Whether you’re passionate about bispecifics, ADCs, AI-driven discovery, or next-gen formats, this is where the future of antibody therapeutics takes shape.
Join us in sunny San Diego or tune in virtually from anywhere!
Showcase Your Research - Add a Poster Presentation
When you register for an in-person or digital Main Conference Pass (or Main Conference + Workshop Pass), you’ll have the exclusive opportunity to elevate your experience by adding a poster presentation for just $199.
This is your chance to:
✓ Showcase your research to leading scientists and industry innovators
✓ Spark meaningful discussions and gain valuable feedback
✓ Expand your professional visibility within the global antibody community
Don’t miss this opportunity to amplify your presence and make an impact!
Partner with the World’s Leading Antibody Event
Seize the opportunity to connect with key decision-makers and industry pioneers shaping the future of antibody therapeutics. As a sponsor of Antibody Engineering & Therapeutics US, your brand will be front and center at the industry’s most influential event, giving you:
✓ Unparalleled access to top biopharma leaders and innovators
✓ Opportunities to showcase your solutions to an engaged audience actively seeking new technologies and partnerships
✓ Direct connections that accelerate your business growth in the antibody and protein therapeutics market
Don’t miss your chance to position your brand at the forefront of antibody innovation.
关于抗体学会
抗体协会是支援从事抗体相关研究和开发的个人、组织的国际性非营利贸易协会。我们研究和分析生物制药行业开发的标靶疗法相关数据，并透过协会的网站、简报、出版品发表成果及解说。该协会除了举办教育性质的网路研讨会和研讨会，同时也扮演着以抗体和 T 细胞受体的下一代定序之生成、使用、共享和标准化为焦点的 AIRR（适应性免疫受体库）社群平台基地这样的角色。此外，我们也与国际机构合作解决抗体界的重要议题。
我们的成员担任Antibody Engineering & Therapeutics的科学顾问。会议的科学议程由我们的会议委员会设计。
